Global Human Insulin Market Data Survey Report 2025

Publisher Name :
Date: 04-Nov-2018
No. of pages: 73

Summary

The global Human Insulin market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

- Sanofi (France)

- Eli Lilly and Company (U.S.)

- Biocon Ltd. (India)

- Julphar (U.A.E.)

- Ypsomed AG (Switzerland)

- Becton

- Becton

- Wockhardt Ltd. (India)

- B. Braun Meselgen AG (Switzerland)

- Biodel Inc(U.S.)

Major applications as follows:

- Insulin Dependent Diabetes Mellitus

- Non-Insulin Dependent Diabetes Mellitus

Major Type as follows:

- Short Acting Human Insulin

- Intermediate Acting Human Insulin

- Premixed Human Insulin

Regional market size, production data and export & import:

- Asia-Pacific

- North America

- Europe

- South America

- Middle East & Africa

Global Human Insulin Market Data Survey Report 2025

Table of Contents

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Sanofi (France)
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Eli Lilly and Company (U.S.)
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biocon Ltd. (India)
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Julphar (U.A.E.)
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Ypsomed AG (Switzerland)
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Becton
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Becton
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Wockhardt Ltd. (India)
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 B. Braun Meselgen AG (Switzerland)
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Biodel Inc(U.S.)
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Insulin Dependent Diabetes Mellitus
4.1.1 Overview
4.1.2 Insulin Dependent Diabetes Mellitus Market Size and Forecast
4.2 Non-Insulin Dependent Diabetes Mellitus
4.2.1 Overview
4.2.2 Non-Insulin Dependent Diabetes Mellitus Market Size and Forecast
5 Market by Type
5.1 Short Acting Human Insulin
5.1.1 Overview
5.1.2 Short Acting Human Insulin Market Size and Forecast
5.2 Intermediate Acting Human Insulin
5.2.1 Overview
5.2.2 Intermediate Acting Human Insulin Market Size and Forecast
5.3 Premixed Human Insulin
5.3.1 Overview
5.3.2 Premixed Human Insulin Market Size and Forecast
6 Conclusion

List of Tables

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi (France)
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company (U.S.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Biocon Ltd. (India)
Tab Sales Revenue, Volume, Price, Cost and Margin of Julphar (U.A.E.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Ypsomed AG (Switzerland)
Tab Sales Revenue, Volume, Price, Cost and Margin of Becton
Tab Sales Revenue, Volume, Price, Cost and Margin of Becton
Tab Sales Revenue, Volume, Price, Cost and Margin of Wockhardt Ltd. (India)
Tab Sales Revenue, Volume, Price, Cost and Margin of B. Braun Meselgen AG (Switzerland)
Tab Sales Revenue, Volume, Price, Cost and Margin of Biodel Inc(U.S.)

List of Figures

Fig Global Human Insulin Market Size and CAGR 2011-2017 (Million USD)
Fig Global Human Insulin Market Size and CAGR 2011-2017 (Volume)
Fig Global Human Insulin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Human Insulin Market Forecast and CAGR 2018-2025 (Volume)
Fig Insulin Dependent Diabetes Mellitus Market Size and CAGR 2011-2017 (Million USD)
Fig Insulin Dependent Diabetes Mellitus Market Size and CAGR 2011-2017 (Volume)
Fig Insulin Dependent Diabetes Mellitus Market Forecast and CAGR 2018-2025 (Million USD)
Fig Insulin Dependent Diabetes Mellitus Market Forecast and CAGR 2018-2025 (Volume)
Fig Non-Insulin Dependent Diabetes Mellitus Market Size and CAGR 2011-2017 (Million USD)
Fig Non-Insulin Dependent Diabetes Mellitus Market Size and CAGR 2011-2017 (Volume)
Fig Non-Insulin Dependent Diabetes Mellitus Market Forecast and CAGR 2018-2025 (Million USD)
Fig Non-Insulin Dependent Diabetes Mellitus Market Forecast and CAGR 2018-2025 (Volume)
Fig Short Acting Human Insulin Market Size and CAGR 2011-2017 (Million USD)
Fig Short Acting Human Insulin Market Size and CAGR 2011-2017 (Volume)
Fig Short Acting Human Insulin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Short Acting Human Insulin Market Forecast and CAGR 2018-2025 (Volume)
Fig Intermediate Acting Human Insulin Market Size and CAGR 2011-2017 (Million USD)
Fig Intermediate Acting Human Insulin Market Size and CAGR 2011-2017 (Volume)
Fig Intermediate Acting Human Insulin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Intermediate Acting Human Insulin Market Forecast and CAGR 2018-2025 (Volume)
Fig Premixed Human Insulin Market Size and CAGR 2011-2017 (Million USD)
Fig Premixed Human Insulin Market Size and CAGR 2011-2017 (Volume)
Fig Premixed Human Insulin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Premixed Human Insulin Market Forecast and CAGR 2018-2025 (Volume)
  • Global Alpha-Glucosidase Inhibitors Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 110
    The Alpha-Glucosidase Inhibitors market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Alpha-Glucosidase Inhibitors industrial chain, this report mainly elaborates the definition, types, applications and major players of Alpha-Glucosidase Inhibitors market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of ......
  • Global Diabetes Drug Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 117
    The Diabetes Drug market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Diabetes Drug industrial chain, this report mainly elaborates the definition, types, applications and major players of Diabetes Drug market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development tre......
  • Global Insulin API Market Study 2016-2026, by Segment (Regular Human Insulin, Insulin Analogue) , by Market (Short Acting Insulin, Intermediate Acting Insulin,) , by Company (Novo Nordisk, Eli Lilly,)
    Published: 15-Oct-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Insulin API market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Regular Human Insulin - Insulin Analogue Demand Coverage (Market Size & Forecast, Consumer Distribution): - Short Acting Insulin - Intermediate Acting Insulin - Long Acting Insulin - Pre-Mix Insulin ......
  • Global Human Insulin Market Study 2016-2026, by Segment (Short Acting Human Insulin, Intermediate Acting Human Insulin,) , by Market (Insulin Dependent Diabetes Mellitus, Non-Insulin Dependent Diabetes Mellitus) , by Company (Sanofi (France) , Eli Lilly and Company (U.S.) ,)
    Published: 13-Oct-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Human Insulin market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Short Acting Human Insulin - Intermediate Acting Human Insulin - Premixed Human Insulin Demand Coverage (Market Size & Forecast, Consumer Distribution): - Insulin Dependent Diabetes Mellitus - Non-Insulin Dependent Di......
  • Global Incretin-Based Drugs Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. ......
  • Global Human Insulin Market Professional Survey Report 2019
    Published: 04-Oct-2019        Price: US 3500 Onwards        Pages: 103
    Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulator......
  • Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Professional Survey Report 2019
    Published: 04-Oct-2019        Price: US 3500 Onwards        Pages: 103
    Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors volume and value at global level, regional level and company level. F......
  • Global Antidiabetics Market Professional Survey Report 2019
    Published: 30-Sep-2019        Price: US 3500 Onwards        Pages: 105
    Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract. The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid ......
  • Global Lixisenatide Market Professional Survey Report 2019
    Published: 26-Sep-2019        Price: US 3500 Onwards        Pages: 107
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II.  The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited manufacturers and distribution channels is anticipated to imped......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs